Atria Wealth Solutions’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.04M Sell
11,370
-44,693
-80% -$4.08M 0.02% 624
2025
Q1
$5.25M Buy
56,063
+12,884
+30% +$1.15M 0.06% 325
2024
Q4
$3.93M Sell
43,179
-7,146
-14% -$682K 0.04% 423
2024
Q3
$5.22M Sell
50,325
-127
-0.3% -$12.9K 0.06% 333
2024
Q2
$4.9M Buy
50,452
+6,494
+15% +$599K 0.05% 349
2024
Q1
$3.96M Buy
43,958
+4,564
+12% +$387K 0.04% 405
2023
Q4
$3.14M Buy
39,394
+500
+1% +$37.6K 0.04% 454
2023
Q3
$2.77M Sell
38,894
-4,959
-11% -$371K 0.04% 465
2023
Q2
$3.38M Sell
43,853
-786
-2% -$60.8K 0.05% 397
2023
Q1
$3.35M Buy
44,639
+7,118
+19% +$529K 0.05% 374
2022
Q4
$2.96M Buy
37,521
+8,926
+31% +$669K 0.05% 387
2022
Q3
$2.01M Buy
28,595
+12,805
+81% +$1M 0.03% 478
2022
Q2
$1.26M Sell
15,790
-8,927
-36% -$698K 0.02% 599
2022
Q1
$1.87M Buy
+24,717
New +$1.96M 0.03% 503

Other funds holding CL

Atria Wealth Solutions's CL Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Colgate-Palmolive (CL) stake by 80% in Q2 2025, selling an estimated $4.08M and leaving 11,370 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #624.

Atria Wealth Solutions first reported a position in CL in Q1 2022 and has held it in 14 quarters since. The position peaked at $5.25M in Q1 2025. 1,916 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Atria Wealth Solutions held 11,370 shares of Colgate-Palmolive worth $1.04M as of Q2 2025.
  • Atria Wealth Solutions sold 44,693 Colgate-Palmolive shares in Q2 2025, an estimated $4.08M.
  • Colgate-Palmolive made up 0.02% of Atria Wealth Solutions's portfolio in Q2 2025, its #624 holding.
  • Atria Wealth Solutions first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Colgate-Palmolive position peaked at $5.25M in Q1 2025.
  • 1,916 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.